Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Revenue: 2020-2024

Historic Revenue for Insight Molecular Diagnostics (IMDX) over the last 5 years, with Dec 2024 value amounting to $1.9 million.

  • Insight Molecular Diagnostics' Revenue rose 126.09% to $260,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 520.87%. This contributed to the annual value of $1.9 million for FY2024, which is 25.15% up from last year.
  • As of FY2024, Insight Molecular Diagnostics' Revenue stood at $1.9 million, which was up 25.15% from $1.5 million recorded in FY2023.
  • Over the past 5 years, Insight Molecular Diagnostics' Revenue peaked at $2.2 million during FY2021, and registered a low of $958,000 during FY2022.
  • Its 3-year average for Revenue is $1.4 million, with a median of $1.5 million in 2023.
  • In the last 5 years, Insight Molecular Diagnostics' Revenue soared by 80.76% in 2021 and then crashed by 56.41% in 2022.
  • Yearly analysis of 5 years shows Insight Molecular Diagnostics' Revenue stood at $1.2 million in 2020, then skyrocketed by 80.76% to $2.2 million in 2021, then slumped by 56.41% to $958,000 in 2022, then surged by 56.89% to $1.5 million in 2023, then rose by 25.15% to $1.9 million in 2024.